Autosomal dominant Alzheimer disease: A unique resource to study CSF biomarker changes in preclinical AD
Our understanding of the pathogenesis of Alzheimer disease (AD) has been greatly influenced by investigation of rare families with autosomal dominant mutations that cause early onset AD. Mutations in the genes coding for Amyloid Precursor Protein (APP), Presenilin 1 (PSEN-1) and Presenilin 2 (PSEN-...
Main Authors: | Suzanne Elizabeth Schindler, Anne M Fagan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-06-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fneur.2015.00142/full |
Similar Items
-
Visual short-term memory relates to tau and amyloid burdens in preclinical autosomal dominant Alzheimer’s disease
by: Daniel J. Norton, et al.
Published: (2020-08-01) -
Current Biomarkers for Alzheimer’s Disease: From CSF to Blood
by: Kun Zou, et al.
Published: (2020-08-01) -
Longitudinal amyloid and tau accumulation in autosomal dominant Alzheimer’s disease: findings from the Colombia-Boston (COLBOS) biomarker study
by: Justin S. Sanchez, et al.
Published: (2021-01-01) -
The Latin American Spanish version of the Face-Name Associative Memory Exam is sensitive to cognitive and pathological changes in preclinical autosomal dominant Alzheimer’s disease
by: Clara Vila-Castelar, et al.
Published: (2020-09-01) -
Interlaboratory proficiency processing scheme in CSF aliquoting: implementation and assessment based on biomarkers of Alzheimer’s disease
by: Piotr Lewczuk, et al.
Published: (2018-08-01)